Note: Ingredients listed on restricted chemical lists
General Information
Version
4
Revision date
2011-05-26
Product name
Streptavidin-Alkaline Phosphatase Conjugate, 2 ml
1.2.1 Relevant identified uses
Industrial applications: Analytical chemistry. Reagent
supplier name
GE Healthcare UK Ltd
Emergency telephone
1-800-424-9300, 1-703-527-3887
Icons in SDS
Company Information
company name
GE Healthcare UK Ltd
GHS Information
Signal word
DANGER!
Section 2
SECTION 2: Hazards identification
This material is considered hazardous by the OSHA Hazard Communication Standard ( 29 CFR 1910. 1200 ) Physical state Liquid. Odor Not available.
Precautionary statements
Do not breathe vapor or mist. Do not ingest. Use only with adequate ventilation. Do not get in eyes, on skin or on clothing. Do not eat, drink or smoke when using this product. Keep container tightly closed. Wash thoroughly after handling. Routes of entry Dermal contact. Eye contact. Inhalation. Ingestion.
Potential Acute Health Effects
Eyes Irritating to eyes. Skin Very toxic in contact with skin. Irritating to skin. Inhalation Very toxic by inhalation. Moderately irritating to the respiratory system. Exposure to decomposition products may cause a health hazard. Serious effects may be delayed following exposure. Ingestion Very toxic if swallowed. Potential chronic health effects
Potential chronic health
Contains material that can cause target organ damage. Carcinogenicity No known significant effects or critical hazards. Mutagenicity No known significant effects or critical hazards.
Teratogenic Effects
No known significant effects or critical hazards. Developmental effects No known significant effects or critical hazards. Fertility effects No known significant effects or critical hazards. Target organs Contains material which causes damage to the following organs: the nervous system, mucous membranes, heart, brain, upper respiratory tract. Contains material which may cause damage to the following organs: kidneys, gastrointestinal tract, cardiovascular system, skin, eyes, central nervous system (CNS). Inhalation Adverse symptoms may include the following: respiratory tract irritation coughing Ingestion No specific data. Skin Adverse symptoms may include the following: irritation redness Eyes Adverse symptoms may include the following: pain or irritation watering redness
Medical Conditions Generally Aggravated by Exposure
Pre-existing disorders involving any target organs mentioned in this MSDS as being at risk may be over-exposure aggravated by over-exposure to this product. See toxicological information (Section 11)